問卷

TPIDB > Search Result

Search Result

篩選

List

3348Cases

2021-04-01 - 2024-12-31

Phase I

Completed
  • Condition/Disease

  • Test Drug

Participate Sites
5Sites

Terminated5Sites

2023-04-22 - 2026-10-30

Phase III

Active
PHase 3, Multicenter, RandOmized, Double-masked, PlacEbo-CoNtrolled Study of TInlarebant to EXplore Safety and Efficacy in the Treatment of Geographic Atrophy (the PHOENIX Study)
  • Condition/Disease

    Geographic Atrophy

  • Test Drug

    錠劑

Participate Sites
4Sites

Recruiting4Sites

2018-04-15 - 2025-04-30

Phase I/II

Active
  • Condition/Disease

  • Test Drug

Participate Sites
1Sites

Terminated1Sites

2024-04-30 - 2027-04-30

Phase I

Active
A Phase 1 Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of VRN110755 in Patients with Epidermal Growth Factor Receptor (EGFR) Mutant Non-small Cell Lung Cancer (NSCLC)
  • Condition/Disease

    Non-small Cell Lung Cancer (NSCLC)

  • Test Drug

    tablet

Participate Sites
5Sites

Recruiting5Sites

2017-10-31 - 2025-06-30

Phase I/II

Active
  • Condition/Disease

  • Test Drug

Participate Sites
3Sites

Terminated3Sites

2019-11-01 - 2029-03-31

Phase I

Active
  • Condition/Disease

  • Test Drug

Participate Sites
3Sites

Recruiting3Sites

2019-09-01 - 2024-12-31

Phase I/II

Completed
  • Condition/Disease

  • Test Drug

Participate Sites
4Sites

Terminated4Sites

2022-06-01 - 2024-12-31

Phase III

Completed
  • Condition/Disease

  • Test Drug

Participate Sites
11Sites

Terminated11Sites

2016-08-01 - 2024-03-31

Phase III

Completed
  • Condition/Disease

  • Test Drug

Participate Sites
6Sites

Terminated6Sites

2021-12-01 - 2022-12-12

Phase II

Completed
  • Condition/Disease

  • Test Drug

Participate Sites
6Sites

Terminated6Sites